EMD Millipore, a Merck KGaA subsidiary has entered into definitive M&A agreement to acquire Biochrom, a Berlin based cell culture media specialist company.
The parties agreed not to disclose the price of this M&A agreement.
The acquisition is subject to customary closing conditions such as the approval of the respective antitrust authority.
It is planned to maintain Biochrom’s operations in Berlin. Biochrom’s activities will be part of EMD Millipore’s Process Solutions business unit.
For further deal information visit Current Agreements (subscription required)
Read: more on M&A deals in pharma, biotech, life science partnering deal news, insights and glossary
Related reports: Merger and Acquisition Terms and Agreements
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity